King-Jones Heidy
Reporting owner on Forms 3, 4 and 5, CIK 1794898.
King-Jones Heidy reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Spyre Therapeutics, Inc. CIK 1636282 | officer (See Remarks) | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | M exercised | +28,933 | $14.5 | 31,778 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -400 | $89.24 | 31,378 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -16,605 | $90.35 | 14,773 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -7,228 | $91.35 | 7,545 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -2,100 | $92.7 | 5,445 | Form 4 |
| Spyre Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -2,600 | $93.46 | 2,845 | Form 4 |
| Spyre Therapeutics, Inc. Stock Option (Right to Buy), derivative | 2026-10-01 | M exercised | -28,933 | $0 | 482,478 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001636282-26-000119 | Spyre Therapeutics, Inc. | 2026-10-02 |